Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 9026573, 7 pages
http://dx.doi.org/10.1155/2016/9026573
Research Article

Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers

1Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa
2Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South Africa
3Department of Family Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa

Received 7 October 2015; Revised 11 January 2016; Accepted 26 January 2016

Academic Editor: Dianne Cooper

Copyright © 2016 Tinyiko G. Makhubele et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Paiardini and M. Müller-Trutwin, “HIV-associated chronic immune activation,” Immunological Reviews, vol. 254, no. 1, pp. 78–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Appay and D. Sauce, “Immune activation and inflammation in HIV-1 infection: causes and consequences,” The Journal of Pathology, vol. 214, no. 2, pp. 231–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. d'Ettorre, M. Paiardini, G. Ceccarelli, G. Silvestri, and V. Vullo, “HIV-associated immune activation: from bench to bedside,” AIDS Research and Human Retroviruses, vol. 27, no. 4, pp. 355–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Kamat, V. Misra, E. Cassol et al., “A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy,” PLoS ONE, vol. 7, no. 2, Article ID e30881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Malherbe, H. C. Steel, S. Cassol et al., “Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection,” Mediators of Inflammation, vol. 2014, Article ID 198413, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. T. L. Miller, W. Borkowsky, L. A. Dimeglio et al., “Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children,” HIV Medicine, vol. 13, no. 5, pp. 264–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Sainz, M. Álvarez-Fuente, and M. L. Navarro, “Structural changes of the arterial wall appear in first decades of life during HIV-infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 65, no. 1, pp. 42–49, 2014. View at Google Scholar
  8. A. M. Sánchez Torres, R. Munoz Muniz, R. Madero, C. Borque, M. J. García-Miguel, and M. I. De José Gómez, “Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children,” European Journal of Pediatrics, vol. 164, no. 5, pp. 271–276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. L. Miller, E. J. Orav, S. E. Lipshultz et al., “Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1,” The Journal of Pediatrics, vol. 153, no. 4, pp. 491–497, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. L. Miller, Y. T. Grant, D. N. Almeida, T. Sharma, and S. E. Lipshultz, “Cardiometabolic disease in human immunodeficiency virus-infected children,” Journal of the Cardiometabolic Syndrome, vol. 3, no. 2, pp. 98–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Yoshioka, W. G. Bradley, P. Shapshak et al., “Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases,” Advances in Neuroimmunology, vol. 5, no. 3, pp. 335–358, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Chiappini, E. Berti, K. Gianesin et al., “Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era,” Cancer Letters, vol. 347, no. 1, pp. 38–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. F. van Eeden and J. C. Hogg, “The response of human bone marrow to chronic cigarette smoking,” The European Respiratory Journal, vol. 15, no. 5, pp. 915–921, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. N. R. Reynolds, “Cigarette smoking and HIV: more evidence for action,” AIDS Education and Prevention, vol. 21, supplement 3, pp. 106–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. L. R. Pacek and R. M. Crum, “A review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts,” Addiction Research & Theory, vol. 23, no. 1, pp. 10–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. D. P. Strachan and D. G. Cook, “Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood,” Thorax, vol. 52, no. 10, pp. 905–914, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. L. L. Jones, A. Hashim, T. McKeever, D. G. Cook, J. Britton, and J. Leonardi-Bee, “Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis,” Respiratory Research, vol. 12, article 5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. L. Benowitz, K. E. Schultz, C. A. Haller, A. H. Wu, K. M. Dains, and P. Jacob III, “Biochemical verification of tobacco use and cessation,” Nicotine & Tobacco Research, vol. 4, no. 2, pp. 149–159, 2002. View at Publisher · View at Google Scholar
  19. E. J. Abrams, J. Weedon, R. W. Steketee et al., “Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants,” The Journal of Infectious Diseases, vol. 178, no. 1, pp. 101–108, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Muechhoff, A. J. Prendergast, and P. J. Goulder, “Immunity to HIV in early life,” Frontiers in Immunology, vol. 5, no. 391, 2014. View at Publisher · View at Google Scholar
  21. N. R. Klatt, N. T. Funderburg, and J. M. Brenchley, “Microbial translocation, immune activation, and HIV disease,” Trends in Microbiology, vol. 21, no. 1, pp. 6–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Liappis, “Reference values of β2 microglobulin concentrations in the serum of children,” Klinische Pädiatrie, vol. 200, no. 1, pp. 67–69, 1988 (German). View at Google Scholar
  23. E. Papasavvas, L. Azzoni, A. Foulkes et al., “Increased microbial translocation in ≤180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age,” The Pediatric Infectious Disease Journal, vol. 30, no. 10, pp. 877–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Crothers, T. A. Griffith, K. A. McGinnis et al., “The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans,” Journal of General Internal Medicine, vol. 20, no. 12, pp. 1142–1145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. G. Feldman, H. Minkoff, M. F. Schneider et al., “Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study,” American Journal of Public Health, vol. 96, no. 6, pp. 1060–1065, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Nahvi and N. A. Cooperman, “Review: the need for smoking cessation among HIV-positive smokers,” AIDS Education and Prevention, vol. 21, supplement 3, pp. 14–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Helleberg, S. Afzal, G. Kronborg et al., “Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study,” Clinical Infectious Diseases, vol. 56, no. 5, pp. 727–734, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Miguez-Burbano, D. Ashkin, A. Rodriguez et al., “Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease,” International Journal of Infectious Diseases, vol. 9, no. 4, pp. 208–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. M. Rossouw, R. Anderson, and C. Feldman, “Impact of HIV infection and smoking on lung immunity and related disorders,” The European Respiratory Journal, vol. 46, no. 6, pp. 1781–1795, 2015. View at Publisher · View at Google Scholar
  30. P. Waweru, R. Anderson, H. Steel, W. D. F. Venter, D. Murdoch, and C. Feldman, “The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV-positive patients in Johannesburg, South Africa,” South African Medical Journal, vol. 103, no. 11, pp. 858–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. G. M. Louwagie and O. A. Ayo-Yusuf, “Tobacco use patterns in tuberculosis patients with high rates of human immunodeficiency virus co-infection in South Africa,” BMC Public Health, vol. 13, article 1031, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. B. R. Lane, S. R. King, P. J. Bock, R. M. Strieter, M. J. Coffey, and D. M. Markovitz, “The C-X-C chemokine IP-10 stimulates HIV-1 replication,” Virology, vol. 307, no. 1, pp. 122–134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Farhang and F. A. Qadir, “Effects of cigarette smoking on some immunological and hematological parameters in male smokers in Erbil city,” Jordan Journal of Biological Sciences, vol. 6, no. 2, pp. 159–166, 2013. View at Publisher · View at Google Scholar
  34. C. Costa, R. Rufino, S. L. Traves, J. R. Lapa E Silva, P. J. Barnes, and L. E. Donnelly, “CXCR3 and CCR5 chemokines in induced sputum from patients with COPD,” Chest, vol. 133, no. 1, pp. 26–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. J. Montpetit, Modulation of monocyte-derived dendritic cell maturation and function by cigarette smoke condensate in a bronchial epithelial cell co-culture model [Ph.D. thesis], Graduate Theses and Dissertations, 2008, http://scholarcommons.usf.edu/etd/413.
  36. E. Stylianou, P. Aukrust, K. Bendtzen, F. Müller, and S. S. Frøland, “Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)—possible immunosuppressive role of IFN-α in HIV infection,” Clinical and Experimental Immunology, vol. 119, no. 3, pp. 479–485, 2000. View at Publisher · View at Google Scholar · View at Scopus